PharmaCielo Announces Issuance of Cease Trade Order

Core Viewpoint - PharmaCielo Ltd. has received a cease trade order from the Ontario Securities Commission due to delays in filing its audited annual consolidated financial statements for the year ended March 31, 2025 [1][2] Group 1: Cease Trade Order Details - The cease trade order prohibits any trading of the Company's securities in Canada, including common shares on the TSX Venture Exchange [1] - The delay in filing the required documents was not due to material accounting issues but rather significant resource demands related to a potential sale of non-core assets [2][3] Group 2: Company Response and Future Actions - The Company is actively working with its accounting staff and external auditors to complete the outstanding filings and expects to remedy the default shortly [4] - PharmaCielo plans to issue a public announcement once the transaction involving non-core assets is finalized and will release further updates once the required documents are filed and the cease trade order is lifted [3][4] Group 3: Company Overview - PharmaCielo Ltd. is a global company focused on ethical and sustainable processing and supplying of pharmaceutical-grade medical cannabis products [5] - The Company's principal subsidiary, PharmaCielo Colombia Holdings S.A.S., is located in Rionegro, Colombia, which is recognized for its ideal conditions for building a sustainable medical cannabis business [6]